Not Yet Recruiting
Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.
NCT06646445
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +14 more
- Locations
-
- Institut Sainte Catherine Avignon, France
- CHU Besançon Besançon, France
- IHFB Cognacq Jay Levallois-Perret, France
- Centre Leon Berard Lyon, France